Compare lab measurements, vendor test histories and original reports for BPC-157 + Ghk-cu + Thymosin BETA-4.
What the BPC-157 + Ghk-cu + Thymosin BETA-4 record shows
Evidence through 2026-09-11
TitrateLab tracks 8 published BPC-157 + Ghk-cu + Thymosin BETA-4 certificate-of-analysis source records through 2026-09-11, each with a recorded purity or measured-versus-label amount result. Across 8 records with a numeric peptide-purity result, including zero, the median reported purity is 99.7%. There are not enough labeled-dose results to report dose accuracy. This is a public convenience sample, not a randomized market survey; one result describes one submitted sample and does not verify other batches.
Published records with a non-null purity or measured-versus-label amount result. Matching uses a normalized compound slug. No deduplication in this archive summary; relays and corrected records can remain separate. Records with neither measurement are excluded here, but can appear in the research overview's exact-token raw-record total. These are not unique certificates or batches. TitrateLab indexes reports from third-party laboratories.
Aggregate calculated: 2026-09-13T21:29:16.188752+00:00. Calculation time is not a test date.
Published records8
Reported purity99.7% median · 8 results
Dose accuracyNot available
EndotoxinNot reported
Evidence dates2026-09-05 to 2026-09-11
Limits and missing evidence
Measured-versus-label dose data were not recorded.
No classifiable endotoxin results were recorded.
Coverage depends on reports that were published and available to ingest.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.